Kazuko Sakai

发表

MS3-1 IMPLEMENTATION OF GENE PANEL TESTING USING NEXT-GENERATION SEQUENCING

Kazuko Sakai, 2019, Neuro-oncology Advances.

Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure.

Kazuko Sakai, Taroh Satoh, Kazuhiko Nakagawa, 2011, Biochemical and biophysical research communications.

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

Masato Terashima, Kazuko Sakai, Kazuto Nishio, 2017, BMC Cancer.

Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway

Kazuko Sakai, N. Saijo, H. Yokote, 2007, Cancer science.

Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung Cancer

Kazuko Sakai, Kazuhiko Nakagawa, Kaoru Tanaka, 2012, Clinical Cancer Research.

A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

Shinichiro Suzuki, Shigeki Shimizu, Kazuko Sakai, 2019, Scientific Reports.

New Era for Next-Generation Sequencing in Japan

Kazuko Sakai, Kazuhiko Nakagawa, Kazuya Fukuoka, 2019, Cancers.

A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer

Yuichi Takiguchi, Hirofumi Mukai, Nobuyuki Yamamoto, 2013, PloS one.

Development of On-Chip Multi-Imaging Flow Cytometry for Identification of Imaging Biomarkers of Clustered Circulating Tumor Cells

Kenji Yasuda, Yohei Miyagi, Mathias Girault, 2014, PloS one.

Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing

Masato Terashima, Shuta Tomida, Kazuko Sakai, 2015, PloS one.

Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)

Shingo Matsumoto, Daisuke Kotani, Chikashi Ishioka, 2018, Cancer science.

In-frame deletion in the EGF receptor alters kinase inhibition by gefitinib.

Kazuko Sakai, N. Saijo, H. Yokote, 2006, The Biochemical journal.

Detection of the T790M mutation of EGFR in plasma of advanced non–small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study)

Kazuko Sakai, Tatsuo Ohira, Kazuhiko Nakagawa, 2016, Oncotarget.

Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer.

Masato Terashima, Masatoshi Kudo, Masayuki Kitano, 2015, Cancer letters.